Charming Medical Ltd (MCTA) stock

MCTAServices-Misc Health & Allied Services, NEC

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 30, 2026Score 3/30

$29.35+0.00 (0.00%)

Close on Nov 5, 2026Market cap $504.17MP/E –Yield –

Charming Medical r&d expenses

Research and development expenses are spending on new products and technology.

Charming Medical has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in Charming Medical's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is MCTA.

Revenue growth-22.7% · median -11.8%

Operating margin-0.6% · median -32.5%

Net margin-0.5% · median -40.4%

Advertisement
300 × 250

See a number that looks wrong?